Rvl-202
Research payments
$159,326
Through program year 2019, $159,326 in research payments was reported against Rvl-202, across 52 payments, paid by Osmotica Pharmaceutical Corp..
- Paid by
- Osmotica Pharmaceutical Corp.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $159,326 | 52 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jason Bacharach Petaluma, CA Named on 4 payments
- Eugene Protzko Havre De Grace, MD Named on 4 payments
- Matthew Paul Danbury, CT Named on 4 payments
- Alan Gruber Rochester, NY Named on 3 payments
- Shane Foster Athens, OH Named on 3 payments
- Jody Abrams Sarasota, FL Named on 3 payments
- Robert Smyth-Medina Mission Hills, CA Named on 3 payments
- Douglas Day Atlanta, GA Named on 2 payments
- Benjamin Lambright Lecanto, FL Named on 2 payments
- David Wirta Newport Beach, CA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.